The YHR180W Antibody (CSB-PA327903XA01SVG) is a polyclonal rabbit-derived antibody designed to target the YHR180W protein in Saccharomyces cerevisiae (baker's yeast, strain ATCC 204508 / S288c). It is primarily used in scientific research for detecting and analyzing the expression, localization, and functional interactions of the YHR180W protein. The antibody is validated for use in ELISA and Western blot (WB) applications, with specificity confirmed via antigen affinity purification .
The antibody is optimized for quantitative detection of YHR180W in yeast lysates. It demonstrates high specificity in ELISA assays, with minimal cross-reactivity reported . Western blot validation confirms its ability to detect the ~25 kDa YHR180W protein in denaturing conditions .
In studies analyzing chromatin structure, the YHR180W Antibody has been used to map histone modifications and gene promoter interactions. For example, it was employed in ChIP experiments to investigate the role of Htz1 (a histone variant) in regulating ribosomal protein gene expression .
The YHR180W gene encodes a single-pass membrane protein of unknown function, localized to the membrane fraction of yeast cells . Its expression is downregulated under stress conditions (e.g., heat shock, oxidative stress), as evidenced by microarray data .
Quantitative RT–PCR analyses using the YHR180W Antibody revealed that gene expression is modulated by chromatin remodeling factors like Swr1 and Arp6. Deletion of arp6 or htz1 genes resulted in a 2.5-fold reduction in YHR180W transcript levels .
ChIP-seq data indicate that YHR180W is associated with telomeric regions of chromosome 3, suggesting a potential role in genome stability . This localization is disrupted in swr1 mutant strains .
The antibody is manufactured by Cusabio, a biotech company specializing in antibody development. It is produced via antigen affinity purification from rabbit serum, ensuring high specificity .
Standard orders require 14–16 weeks for production, reflecting the custom synthesis process .
STRING: 4932.YHR180W
The YHR180W gene encodes a single-pass membrane protein in Saccharomyces cerevisiae (baker's yeast, strain ATCC 204508 / S288c) with currently unknown specific function. This protein has generated research interest primarily due to its localization patterns and expression dynamics under different cellular conditions.
The protein's expression is notably downregulated under various stress conditions including heat shock and oxidative stress, as demonstrated by microarray analysis. This stress-responsive characteristic makes it a valuable target for studying cellular adaptation mechanisms. Additionally, ChIP-seq data has revealed association with telomeric regions of chromosome 3, suggesting potential involvement in genome stability processes.
Research applications for the YHR180W protein typically include studies of membrane protein trafficking, telomere biology, stress response mechanisms, and chromatin structure analysis. The protein serves as a model for investigating how single-pass membrane proteins are regulated in eukaryotic systems.
The YHR180W Antibody (CSB-PA327903XA01SVG) has been validated for use in several key laboratory applications, primarily ELISA and Western blot (WB) techniques. These validations ensure researchers can confidently use the antibody for specific detection of the target protein.
For Western blot applications, the antibody successfully detects the ~25 kDa YHR180W protein in denatured yeast cell lysates. The antibody's specificity makes it suitable for quantitative analysis of protein expression levels across different experimental conditions or genetic backgrounds.
In ELISA applications, the antibody demonstrates high sensitivity and minimal cross-reactivity, making it appropriate for quantitative detection of YHR180W in complex biological samples. Beyond these core applications, the antibody has also been employed in chromatin immunoprecipitation (ChIP) experiments to investigate histone modifications and gene promoter interactions, particularly in studies examining the role of histone variant Htz1 in regulating ribosomal protein gene expression.
While specific storage conditions for the YHR180W antibody aren't explicitly stated in the search results, standard antibody storage and handling protocols should be applied to maintain functionality. Based on comparable polyclonal antibodies like the HERC4 antibody described in the search results, the following guidelines are recommended:
Storage temperature is typically -20°C for antibody preparations, with avoidance of repeated freeze/thaw cycles to preserve antibody integrity . Most antibody preparations include glycerol and/or sodium azide in phosphate-buffered saline (PBS) at neutral pH (approximately 7.3-7.4) to maintain stability during freeze/thaw cycles and prevent microbial growth .
For handling during experiments, keep the antibody on ice when in use, and return to -20°C promptly after use. Aliquoting stock solutions into smaller volumes for single-use applications is recommended to avoid repeated freeze/thaw cycles. When diluting for specific applications, use fresh, sterile buffers appropriate for the intended technique (such as TBST or PBST for Western blotting).
YHR180W expression demonstrates notable regulation patterns under various experimental conditions, making it a useful model for studying gene expression dynamics. Microarray data indicates that YHR180W expression is significantly downregulated under stress conditions, including heat shock and oxidative stress. This pattern suggests the protein may be involved in normal cellular homeostasis rather than stress response mechanisms.
Quantitative RT-PCR analyses using the YHR180W Antibody have revealed that gene expression is strongly modulated by chromatin remodeling factors. Specifically, deletion of chromatin remodeling genes like arp6 or htz1 results in approximately 2.5-fold reduction in YHR180W transcript levels. This finding indicates that proper chromatin structure maintenance is essential for normal YHR180W expression.
Additionally, the protein's association with telomeric regions, as shown by ChIP-seq data, suggests potential cell cycle-dependent regulation or involvement in chromosome stability mechanisms. This localization is disrupted in swr1 mutant strains, further reinforcing the relationship between chromatin remodeling and YHR180W function.
Optimizing YHR180W Antibody for ChIP studies requires careful consideration of several experimental parameters to ensure specificity and efficiency. Based on its successful use in previous ChIP experiments investigating histone modifications and gene promoter interactions, the following methodological approaches are recommended:
For chromatin preparation, crosslinking conditions should be carefully optimized. Starting with 1% formaldehyde for 10 minutes at room temperature is standard, but YHR180W's membrane localization may benefit from extended crosslinking times (up to 15 minutes) to capture transient DNA interactions. Sonication parameters should be empirically determined to generate chromatin fragments of 200-500 bp, which is optimal for most ChIP applications.
Antibody concentration requires careful titration. Begin with 2-5 μg of antibody per ChIP reaction and adjust based on signal-to-noise ratio in pilot experiments. Pre-clearing lysates with protein A/G beads before adding the YHR180W antibody can significantly reduce background. Including appropriate controls is critical: use non-immune rabbit IgG as a negative control, and if studying known YHR180W-associated regions (such as telomeric regions of chromosome 3), include primers for these regions as positive controls.
When analyzing ChIP-seq data involving YHR180W, special attention should be paid to telomeric regions, as previous research has established associations between YHR180W and telomeres on chromosome 3. Bioinformatic analysis should include tools specifically designed to handle repetitive sequences often found in telomeric regions.
For optimal Western blot results with YHR180W Antibody, several technical considerations should be implemented based on the properties of this antibody and the target protein. Since YHR180W is a membrane protein, sample preparation is critical. Cell lysis should be performed using buffers containing non-ionic detergents like NP-40 or Triton X-100 (0.5-1%) to efficiently solubilize membrane proteins. For yeast samples, mechanical disruption methods like bead beating may be necessary for complete lysis.
Protein separation should use standard SDS-PAGE gels, with 10-12% acrylamide concentration being appropriate for resolving the ~25 kDa YHR180W protein. Transfer conditions should be optimized for membrane proteins—using PVDF membranes rather than nitrocellulose and adding 0.1% SDS to transfer buffer can improve efficiency for hydrophobic proteins.
Based on protocols for similar polyclonal antibodies, blocking should be performed with 5% non-fat dry milk or BSA in TBST for 1 hour at room temperature. For primary antibody incubation, a dilution range of 1:500 to 1:2000 is typically effective for polyclonal antibodies in Western blot applications , with overnight incubation at 4°C providing optimal results.
Signal detection methods should be chosen based on expected expression levels—chemiluminescence for standard detection or fluorescence-based methods for precise quantification. When analyzing results, verification of the observed molecular weight against the expected ~25 kDa is essential for confirming specificity.
Implementing appropriate controls is crucial for ensuring reliable and interpretable results when using the YHR180W Antibody. For all applications, a negative control using non-immune IgG from the same species (rabbit) should be included to establish background binding levels.
For Western blot applications, several specific controls are recommended. A positive control using wild-type yeast lysate known to express YHR180W should be included alongside experimental samples. A negative control using YHR180W knockout/deletion strain lysate provides confirmation of antibody specificity. Loading controls using antibodies against constitutively expressed proteins (like GAPDH or actin) should be used to normalize protein loading across samples. Additionally, peptide competition assays, where the antibody is pre-incubated with excess immunizing peptide before use, can confirm binding specificity.
For localization studies, an isotype control antibody should be used alongside the YHR180W antibody to establish background fluorescence levels. Additionally, fluorescent signals should be compared between wild-type yeast and YHR180W deletion strains.
Chromatin remodeling factors have significant effects on both YHR180W expression and localization, providing insights into the regulatory mechanisms governing this gene. Quantitative RT-PCR analyses have demonstrated that YHR180W expression is strongly influenced by the SWR1 chromatin remodeling complex components. Specifically, deletion of either arp6 or htz1 genes results in approximately 2.5-fold reduction in YHR180W transcript levels.
The SWR1 complex is responsible for incorporating the histone variant H2A.Z (encoded by HTZ1 in yeast) into chromatin. The significant drop in YHR180W expression in these mutants suggests that proper H2A.Z deposition is required for optimal YHR180W transcription. This dependency indicates that YHR180W may be regulated through chromatin structure rather than specific transcription factors.
Regarding localization, ChIP-seq data have established that YHR180W is associated with telomeric regions of chromosome 3 in wild-type cells. Importantly, this localization pattern is disrupted in swr1 mutant strains. This finding suggests that the SWR1 complex is not only required for proper expression but also for correct genomic positioning of YHR180W, potentially through establishment of appropriate chromatin boundaries or domains.
The dual impact of chromatin remodeling factors on both expression and localization of YHR180W makes this gene a valuable model for studying how nuclear architecture influences gene regulation in eukaryotes.
Several methodological approaches can be employed to investigate YHR180W interactions with other proteins, taking advantage of the available YHR180W Antibody. Co-immunoprecipitation (Co-IP) represents a powerful approach for identifying protein interaction partners. Using the YHR180W Antibody, researchers can immunoprecipitate the protein complex from yeast lysates and identify interacting partners through mass spectrometry or Western blot analysis. For membrane proteins like YHR180W, addition of mild detergents (0.5-1% NP-40 or digitonin) is critical to maintain protein-protein interactions while solubilizing membrane components.
Proximity-based labeling methods offer an alternative approach for identifying interactions in their native cellular context. Techniques like BioID or APEX2 involve fusing a biotin ligase to YHR180W, allowing biotinylation of proximal proteins, which can then be purified using streptavidin and identified by mass spectrometry. This approach is particularly valuable for capturing transient or weak interactions that might be lost during traditional Co-IP procedures.
Fluorescence microscopy techniques can visualize co-localization or direct interactions. Fluorescence resonance energy transfer (FRET) or bimolecular fluorescence complementation (BiFC) can detect direct protein-protein interactions in vivo. In FRET applications, YHR180W and a potential interacting protein are tagged with compatible fluorophores, and energy transfer between fluorophores indicates close proximity (<10 nm).
Genetic interaction screens provide complementary evidence for functional relationships. Synthetic genetic array (SGA) analysis, where a YHR180W deletion strain is crossed with a library of yeast deletion strains, can identify genes with functional relationships to YHR180W through growth phenotypes of double mutants.
Non-specific binding is a common challenge when working with antibodies, and several methodological approaches can be implemented to minimize this issue with YHR180W Antibody. The first step in troubleshooting involves optimizing blocking conditions. For Western blot applications, extending blocking time to 2 hours or overnight at 4°C can significantly reduce background. Testing different blocking agents (5% BSA, 5% non-fat dry milk, or commercial blocking buffers) can identify the optimal formulation for YHR180W antibody specificity.
Antibody dilution should be carefully titrated. Starting with the recommended dilution range (likely 1:500 to 1:2000 for Western blot applications, based on similar antibodies ), researchers should test multiple dilutions to find the optimal concentration that maximizes specific signal while minimizing background. Including competing proteins (like 1-5% BSA) in the antibody dilution buffer can also help reduce non-specific interactions.
Washing steps are critical for reducing background. Increasing the number of washes (5-6 times for 5-10 minutes each) and wash stringency (by adding up to 0.1% SDS or increasing Tween-20 concentration to 0.1-0.3% in wash buffers) can effectively remove non-specifically bound antibody. For particularly problematic non-specific binding, high-salt washes (up to 500 mM NaCl) may be employed.
Pre-adsorption of the antibody can dramatically improve specificity. Incubating the diluted antibody with lysate from YHR180W knockout yeast for 1-2 hours prior to use can effectively remove antibodies that bind to off-target proteins. For Western blot applications specifically, using freshly prepared samples and ensuring complete protein denaturation with adequate SDS and heating can improve specificity by fully exposing the target epitope.
The reported association of YHR180W with telomeric regions of chromosome 3 represents an intriguing avenue for research into chromosome organization and stability. To investigate this association, several methodological approaches utilizing the YHR180W Antibody can be implemented.
Chromatin immunoprecipitation followed by qPCR (ChIP-qPCR) offers a targeted approach to confirm and quantify YHR180W enrichment at specific telomeric regions. This method requires designing PCR primers that specifically amplify telomeric and subtelomeric regions of chromosome 3. The relative enrichment of these regions in YHR180W ChIP samples compared to input and IgG controls provides quantitative evidence of association. For comprehensive analysis, primers should be designed to cover both telomeric repeats and unique subtelomeric sequences at various distances from the chromosome end.
For genome-wide analysis of YHR180W binding patterns, ChIP-seq provides high-resolution mapping of all binding sites. This approach has previously indicated telomeric association of YHR180W and can be extended to examine binding patterns under different conditions or genetic backgrounds. Special bioinformatic consideration is needed for telomeric repeat regions, which are often filtered out in standard ChIP-seq pipelines due to their repetitive nature.
To directly visualize YHR180W localization at telomeres, immunofluorescence microscopy using the YHR180W Antibody in combination with fluorescent markers for telomeres (like Rap1) can demonstrate co-localization. Super-resolution microscopy techniques like STORM or PALM can provide nanometer-scale resolution of this association.
Genetic approaches complement these direct detection methods. Examining YHR180W binding in mutants affecting telomere structure or function (like yku70Δ, sir2Δ, or rap1 mutants) can reveal dependencies and functional relationships with the telomere maintenance machinery.
Given the currently unknown function of YHR180W, systematic approaches using the YHR180W Antibody can help elucidate its biological role. Phenotypic analysis of YHR180W deletion or overexpression strains represents a fundamental approach. Using the antibody to confirm successful deletion or overexpression, researchers can then examine effects on growth rate, stress resistance, cell morphology, and other phenotypes. Particularly relevant would be examining telomere length, structure, and stability given the protein's association with telomeric regions.
Transcriptome analysis (RNA-seq) of YHR180W mutants can identify affected pathways, potentially revealing the functional network in which YHR180W operates. The antibody can be used to confirm YHR180W expression levels in experimental and control samples.
Proteomic approaches provide complementary insights. Immunoprecipitation using the YHR180W Antibody followed by mass spectrometry can identify interaction partners, offering clues about function based on known roles of these partners. SILAC or TMT labeling can be combined with this approach for quantitative comparison of the interactome under different conditions.
Localization studies using the antibody for immunofluorescence microscopy, particularly under different stress conditions or cell cycle stages, can reveal dynamic behavior relevant to function. Co-localization with markers for specific cellular compartments can provide additional context.
Evolutionary analysis can provide functional insights by examining conservation patterns. If YHR180W homologs exist in other species where function is better characterized, this information can guide hypothesis generation for the yeast protein.